Table 2.
Onychoscopic features | SLE ( N = 54) | DM ( N = 32) | SSc ( N = 51) | p -Value (among CTDs) | Controls ( N = 108) | p -Value (CTDs vs. controls) |
---|---|---|---|---|---|---|
Tortous capillaries N (%) | 48 (88.8%) | 31 (96.8%) | 50 (98%) | 0.125 | 96 (88.8%) | 0.125 |
Bushy capillaries N (%) | 27 (50%) | 21 (65.6%) | 10 (19.6%) | <0.001* | 4 (3.7%) | <0.001* |
Elongated capillaries N (%) | 12 (22.2%) | 3 (9.3%) | 4 (7.8%) | 0.073 | 4 (3.7%) | 0.003* |
Subpapillary plexus N (%) | 28 (51.8%) | 9 (28.1%) | 8 (15.6%) | <0.001* | 15 (13.8%) | <0.001* |
Hemorrhage N (%) | 10 (18.5%) | 11 (34.4%) | 26 (50.9%) | 0.002* | 3 (2.7%) | <0.001* |
Enlarged capillaries N (%) | 25 (46.2%) | 21 (65.6%) | 38 (74.5%) | 0.01* | 27 (25%) | <0.001* |
Disorganized capillaries N (%) | 43 (79.6%) | 31 (96.8%) | 46 (90.1%) | 0.05 | 21 (19.4%) | <0.001* |
Avascular areas N (%) | 41 (75.9%) | 30 (93.7%) | 49 (96%) | 0.004* | 10 (9.2%) | <0.001* |
Density (mean ± SD) | 6.83 ± 1.95 | 5.31 ± 1.86 | 5.09 ± 1.69 | 0.592 | 7.43 ± 1.20 | <0.001* |
CTDs, connective tissue diseases; DM, dermatomyositis; SD, standard deviation; SLE, systemic lupus erythematosus; SSc, systemic sclerosis.
Statistically significant.